Cytokine Induced Killer (CIK) Cells In Leukemia Patients

Clinical trial NCT01186809 · COMPLETED

Trial details

NCT number: NCT01186809
Sponsor: A.O. Ospedale Papa Giovanni XXIII
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hematologic Malignancies

Start date: 2009-07-01
Primary completion: 2016-09-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.